High Evidence (L1-L2)
Candidates that may be prioritised for clinical evaluation
Criteria
| Level | Definition | Clinical meaning |
|---|---|---|
| L1 | Multiple Phase 3 RCTs / systematic reviews | Strong support; clinical use may be considered |
| L2 | Single RCT or multiple Phase 2 trials | Moderate support; validation trials can be designed |
L1 (1 drugs)
| Drug | Indications | Link |
|---|---|---|
| ALUMINUM HYDROXIDE | View report |
L2 (1 drugs)
| Drug | Indications | Link |
|---|---|---|
| ASCORBIC ACID | View report |
Disclaimer
This report is for academic research reference only and does not constitute medical advice. Always follow your physician's instructions; never adjust medication on your own. Any drug repurposing decision requires full clinical validation and regulatory review.
Reviewed by: 藥提醒科技有限公司 (yao.care)
This report is for academic research reference only and does not constitute medical advice. Always follow your physician's instructions; never adjust medication on your own. Any drug repurposing decision requires full clinical validation and regulatory review.
Reviewed by: 藥提醒科技有限公司 (yao.care)